Investors & Media
IR News
- Jan 10, 2020 Santen Pharmaceutical Signs Partnership Agreement with ITU Supporting ITU and WHO initiative 'Be He@lthy, Be Mobile' in Ophthalmology
- Jan 06, 2020 Santen Announces the Construction of China Second Plant
- Dec 23, 2019 Santen Announces Topline Result from Phase II Clinical Trial of DE-127 for Patients with Mild and Moderate Myopia
Management Policies
- CEO Message
- Santen's Values
- Santen's Vision
- Medium Term Management Plan
- Corporate Governance
- Disclosure Policy
- Forward-Looking Statement
IR Library
- Consolidated Performance
- Presentation Materials · videos
- Annual Report
- Data Book
- Pipeline
- Materials for the General Meeting of Shareholders
